Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Masserini

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
ISRN Biochemistry|May 5, 2015
Nanoparticles for brain drug deliveryMassimo Masserini
Maturitas|January 21, 2012
Nanotechnology for neurodegenerative disordersFrancesca Re, Maria Gregori, Massimo Masserini
Nanomedicine : Nanotechnology, Biology, and Medicine|May 30, 2012
Nanotechnology for neurodegenerative disordersFrancesca Re, Maria Gregori, Massimo Masserini
Nanomedicine (London, England)|May 2, 2015
Nanomedicine for the treatment of Alzheimer's diseaseMaria Gregori, Massimo Masserini, Simona Mancini
FEBS Letters|January 27, 2004
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cellsLaura Botto, Massimo Masserini, Arianna Cassetti, et al.
The Italian Journal of Biochemistry|January 14, 2005
GPI-anchored proteins and lipid raftsVanessa Sangiorgio, Marina Pitto, Paola Palestini, et al.
International Journal of Biological Macromolecules|November 20, 2020
The interaction of Aβ42 peptide in monomer, oligomer or fibril forms with sphingomyelin/cholesterol/ganglioside bilayersHasna Ahyayauch, Massimo Masserini, Félix M Goñi, et al.
Molecular and Cellular Neurosciences|June 13, 2009
Pin1 affects Tau phosphorylation in response to Abeta oligomersAlessandra Bulbarelli, Elena Lonati, Emanuela Cazzaniga, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2002
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systemsMassimo Masserini, Paola Palestini, Marina Pitto, et al.
Journal of Biomedical Nanotechnology|August 30, 2019
Nanomedicine for the Treatment of Alzheimer's DiseaseBeatrice Formicola, Alysia Cox, Roberta Dal Magro, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
ISRN Biochemistry|May 5, 2015
Nanoparticles for brain drug deliveryMassimo Masserini
Maturitas|January 21, 2012
Nanotechnology for neurodegenerative disordersFrancesca Re, Maria Gregori, Massimo Masserini
Nanomedicine : Nanotechnology, Biology, and Medicine|May 30, 2012
Nanotechnology for neurodegenerative disordersFrancesca Re, Maria Gregori, Massimo Masserini
Nanomedicine (London, England)|May 2, 2015
Nanomedicine for the treatment of Alzheimer's diseaseMaria Gregori, Massimo Masserini, Simona Mancini
FEBS Letters|January 27, 2004
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cellsLaura Botto, Massimo Masserini, Arianna Cassetti, et al.
The Italian Journal of Biochemistry|January 14, 2005
GPI-anchored proteins and lipid raftsVanessa Sangiorgio, Marina Pitto, Paola Palestini, et al.
International Journal of Biological Macromolecules|November 20, 2020
The interaction of Aβ42 peptide in monomer, oligomer or fibril forms with sphingomyelin/cholesterol/ganglioside bilayersHasna Ahyayauch, Massimo Masserini, Félix M Goñi, et al.
Molecular and Cellular Neurosciences|June 13, 2009
Pin1 affects Tau phosphorylation in response to Abeta oligomersAlessandra Bulbarelli, Elena Lonati, Emanuela Cazzaniga, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2002
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systemsMassimo Masserini, Paola Palestini, Marina Pitto, et al.
Journal of Biomedical Nanotechnology|August 30, 2019
Nanomedicine for the Treatment of Alzheimer's DiseaseBeatrice Formicola, Alysia Cox, Roberta Dal Magro, et al.
Pageof 7